- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech Sustainable Track Record
Indian Pharmaceuticals & Biotech Sustainable Track Record
Results
12
0 new
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
12 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
540737 | ₹634.65 | -6.7% | -6.5% | ₹8.2b | n/a | PE29.3x | n/a | 0% | ||
AJANTPHARM | ₹2,954.50 | 5.3% | 36.8% | ₹369.0b | ₹3,031.30 | PE42.2x | E16.3% | 1.9% | ||
500420 | ₹3,371.90 | -1.4% | 46.9% | ₹1.1t | ₹3,533.07 | PE63.3x | E22.6% | 0.8% | ||
NATCOPHARM | ₹1,397.35 | 0.6% | 70.8% | ₹250.3b | ₹1,337.27 | PE12.9x | E-20.1% | 0.4% | ||
500488 | ₹29,791.25 | 4.4% | 31.1% | ₹633.0b | ₹28,331.43 | PE49.3x | E10.9% | 1.4% | ||
524632 | ₹129.88 | 21.5% | 328.3% | ₹5.7b | n/a | PE39.4x | n/a | 0.8% | ||
JSLL | ₹2,158.15 | -5.3% | 263.7% | ₹53.7b | n/a | PE63.7x | n/a | 0.2% | ||
INDSWFTLAB | ₹106.45 | -1.7% | -0.3% | ₹6.3b | n/a | PE1.7x | n/a | n/a | ||
524212 | ₹280.85 | 1.2% | 117.0% | ₹9.2b | n/a | PE17.4x | n/a | n/a | ||
531569 | ₹378.05 | 2.4% | 105.8% | ₹4.5b | n/a | PE64.9x | n/a | n/a | ||
539561 | ₹5.00 | -3.8% | -80.0% | ₹2.0b | n/a | PE8.4x | n/a | n/a | ||
BETA | ₹1,989.80 | -1.3% | 39.5% | ₹19.1b | n/a | PE46.7x | n/a | n/a |
Page 1 of 1